WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996004914) TRIAZINE DERIVATIVE AND MEDICINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/004914    International Application No.:    PCT/JP1995/001577
Publication Date: 22.02.1996 International Filing Date: 08.08.1995
Chapter 2 Demand Filed:    20.02.1996    
IPC:
A61K 31/53 (2006.01), A61K 31/5377 (2006.01), A61K 31/55 (2006.01)
Applicants: NIPPON SHINYAKU CO., LTD. [JP/JP]; 14, Kisshoin-nishinoshomonguchicho, Minami-ku, Kyoto-shi, Kyoto 601 (JP) (For All Designated States Except US).
UEDA, Fusao [JP/JP]; (JP) (For US Only).
OZAKI, Takayuki [JP/JP]; (JP) (For US Only).
NAKAMURA, Ken-ichi [JP/JP]; (JP) (For US Only)
Inventors: UEDA, Fusao; (JP).
OZAKI, Takayuki; (JP).
NAKAMURA, Ken-ichi; (JP)
Priority Data:
6/185810 08.08.1994 JP
Title (EN) TRIAZINE DERIVATIVE AND MEDICINE
(FR) DERIVE DE TRIAZINE ET MEDICAMENT
Abstract: front page image
(EN)A medicine containing as the active ingredient a triazine derivative represented by general formula (I), a solvate thereof, or a salt thereof and being useful as a hepatitis remedy, wherein R?1¿ and R?2¿ represent each independently hydrogen or (un)substituted alkyl, aralkyl or alkenyl, or NR?1¿R?2¿ represents a cyclic amino group which may bear, in addition to the pertinent nitrogen atom, nitrogen, oxygen or sulfur as the ring atom and may be substituted, provided the case where NR?1¿R?2¿ represents NH¿2? is excluded.
(FR)Médicament contenant en tant qu'ingrédient actif un dérivé de triazine de formule générale (I), un solvate ou un sel dudit dérivé, utile contre l'hépatite. Dans ladite formule, R?1¿ et R?2¿ représentent chacun indépendamment hydrogène ou alkyle, aralkyle ou alcényle substitués ou non substitués, ou NR?1¿R?2¿ représente un groupe amino cyclique qui peut porter, en plus de l'atome d'azote pertinent, de l'azote, de l'oxygène ou du soufre en tant qu'atome cyclique, à condition que le cas dans lequel NR?1¿R?2¿ représente NH¿2? soit exclu.
Designated States: AU, BR, CA, CN, FI, HU, JP, KR, MX, NO, NZ, RU, UA, US, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)